Not recruitingISRCTN55819922
Effect of paroxetine treatment on glycaemic control and quality of life in mildly depressed type two diabetic subjects: a double-blind randomised placebo controlled six month trial
Research studyFinlandDepression
Understand this study
- Listed locations
- Finland
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- GlaxoSmithKline (Finland)
- Sponsor type
- Unknown or unclear
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- Finland
- Age range
- Not clearly listed
- Official registry ID
- ISRCTN55819922
- Official title
Show the full official title
Effect of paroxetine treatment on glycaemic control and quality of life in mildly depressed type two diabetic subjects: a double-blind randomised placebo controlled six month trial
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Finland
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is GlaxoSmithKline (Finland).
Is this study still recruiting?
The registry lists this study as not recruiting.
Want to explore more studies?
Explore studiesRelated studies
A randomised controlled trial of bright light and exercise for depressive symptoms
Differential response to right unilateral electroconvulsive therapy (ECT) in depressed patients: impact of comorbidity and severity of illness